Medicago announces production of a viable vaccine candidate for COVID-19
Medicago Immediate Press Release English media contact: Alissa Von Bargen 1-647-234-5975Alissa.VonBargen@gcicanada.com The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease QUEBEC CITY, March 12, 2020 – Medicago, a biopharmaceutical company headquartered in Quebec City, […]